142 filings
8-K
INDP
Indaptus Therapeutics Inc
9 Aug 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
INDP
Indaptus Therapeutics Inc
29 Jul 21
Intec Announces $30 Million Private Placement Ahead of Decoy Merger
5:12pm
8-K
INDP
Indaptus Therapeutics Inc
23 Jul 21
Other Events
4:34pm
8-K
INDP
Indaptus Therapeutics Inc
16 Jul 21
Other Events
5:07pm
8-K
INDP
Indaptus Therapeutics Inc
22 Jun 21
Submission of Matters to a Vote of Security Holders
8:57am
8-K
ww2znv y7e
30 Apr 21
Entry into a Material Definitive Agreement
12:00am
8-K
5owty4pox765
15 Mar 21
Intec Pharma and Decoy Biosystems Announce Merger Agreement
8:40am
8-K
my48oqx9 2winwreqt3
8 Feb 21
Departure of Directors or Certain Officers
7:00am
8-K
ra3gkvp
9 Dec 20
Intec Pharma Announces Cannabinoid Research Collaboration with GW Pharma
7:07am
8-K
ww3sn3zxp9s501k
5 Nov 20
Intec Pharma Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:11am
8-K
p66of17 s83r
29 Oct 20
Intec Pharma Announces 1-for-20 Reverse Share Split
8:21am
8-K
rd858ms po
8 Oct 20
Intec Pharma Announces New Research Collaboration Agreement with MSD
7:08am
8-K
1fqxd
2 Oct 20
Departure of Directors or Certain Officers
4:34pm
8-K
7eo1 122dw6j
18 Sep 20
Departure of Directors or Certain Officers
4:30pm
8-K
6oeq6eo2 4890pze3
10 Aug 20
Intec Pharma Announces Pricing of $4.9 Million Registered Direct Offering
8:40am
8-K
7yhljt bkhak3hs
5 Aug 20
Intec Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
7:08am
8-K
382rb e64
17 Jul 20
Departure of Directors or Certain Officers
4:30pm
8-K
8iz31vk
8 Jun 20
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:00pm
8-K
pcmriffp6zqenqz0
11 May 20
Intec Pharma Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:25pm
8-K
lamziz9 vflh
6 May 20
Intec Pharma Announces $5.0 Million Registered Direct Offering
10:44am